Efficacy of varenicline, an [alpha]4[beta]2 nicotinic acetylcholine receptor partial agonist vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial

Article Abstract:

A study was conducted to determine the efficiency and safety of varenicline for smoking cessation compared with placebo or sustained release bupropion (bupropion SR). Varenicline was found to be efficacious, safe and well-tolerated cessation pharmacotherapy and its short-term and long-term efficacy exceeded that of both placebo and bupropion SR.

Specialty outpatient clinics, not elsewhere classified, Outpatient Mental Health and Substance Abuse Centers, Antismoking Programs, Health aspects, Drug therapy, Smoking cessation programs, Smoking cessation, Smoking, Clinical report, Varenicline

---

Management of antiphospholipid antibody syndrome: A systematic review

Article Abstract:

A study was conducted to systematically review the evidence for treatment of thrombosis risk in patients with antiphospholipid antibodies or APS. In patients with APS, moderate-intensity warfarin is effective for preventing recurrent venous thrombosis and perhaps also arterial thrombosis.

United States, Usage, Prevention, Causes of, Risk factors, Antiphospholipid syndrome, Thrombosis, Warfarin, Blood clot

---

Similar abstracts:

• Abstracts: Medical treatment of peripheral arterial disease. Does the clinical examination predict lower extremity peripheral arterial disease?
• Abstracts: Does the clinical examination predict lower extremity peripheral arterial disease? Does this patient have influenza?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.